Elevated ALCAM shedding in colorectal cancer correlates with poor patient outcome. - Wikidata - wikimedia - TriplyDB

Elevated ALCAM shedding in colorectal cancer correlates with poor patient outcome.

Elevated ALCAM shedding in colorectal cancer correlates with poor patient outcome.

http://www.wikidata.org/entity/Q39173902

about

ALCAM/CD166 is a TGF-β-responsive marker and functional regulator of prostate cancer metastasis to bone Prognostic value of CD166 expression in cancers of the digestive system: a systematic review and meta-analysis.Protein shedding in urothelial bladder cancer: prognostic implications of soluble urinary EGFR and EpCAM.Shed urinary ALCAM is an independent prognostic biomarker of three-year overall survival after cystectomy in patients with bladder cancer.Proteomic Identification of Cysteine Cathepsin Substrates Shed from the Surface of Cancer Cells.Activated leukocyte cell adhesion molecule (CD166): an "inert" cancer stem cell marker for non-small cell lung cancer?A systematic evaluation for the potential translation of CD166-related expression as a cancer biomarker.Clinicopathological, prognostic and predictive value of CD166 expression in colorectal cancer: a meta-analysis.Targeting ADAM17 inhibits human colorectal adenocarcinoma progression and tumor-initiating cell frequency.Alternative splicing of ALCAM enables tunable regulation of cell-cell adhesion through differential proteolysis.Activated leukocyte cell adhesion molecule (ALCAM) is a marker of recurrence and promotes cell migration, invasion, and metastasis in early-stage endometrioid endometrial cancer.ALCAM shedding at the invasive front of the tumor is a marker of myometrial infiltration and promotes invasion in endometrioid endometrial cancer.Exploring the roles of urinary HAI-1, EpCAM & EGFR in bladder cancer prognosis & risk stratification.

P2860

Q34112011-2BFE6439-D82C-4C3A-B866-0C31932B85D6 Q34936453-3F0C10A3-CFF7-4609-9231-AAF40E3BF9E5 Q35198309-085AD253-C9DC-46D4-9AB9-3E30B70ADE18 Q37702349-A65CC1D6-26FA-46A2-BA3E-8CF79CADF4C3 Q38409707-BEB747CA-2136-4E1A-9190-E0099BEC1C8C Q39026693-8BF19AB7-81B2-4331-B68A-2AB6A98BF387 Q39615435-C16AD716-525A-4410-850C-1FFC13FD142E Q42362789-99DC8A50-6FB5-49B3-844D-C9A1AD8B6956 Q42371503-24721E34-3500-44C3-80C8-205E65876F68 Q49913406-91599BA6-FA55-41CB-AB79-043E5B54937C Q51311386-4B6E580B-2815-4F48-9D2E-7964736A1A37 Q52571266-4BA39672-83AF-43E6-8A82-18DDAFD893DC Q55260461-B8201711-93BB-4F46-BD9D-A1CF7955024A

P2860

Elevated ALCAM shedding in colorectal cancer correlates with poor patient outcome.

http://www.wikidata.org/entity/Q39173902

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Elevated ALCAM shedding in colorectal cancer correlates with poor patient outcome.

@en

Elevated ALCAM shedding in colorectal cancer correlates with poor patient outcome.

@nl

type

label

Elevated ALCAM shedding in colorectal cancer correlates with poor patient outcome.

@en

Elevated ALCAM shedding in colorectal cancer correlates with poor patient outcome.

@nl

prefLabel

Elevated ALCAM shedding in colorectal cancer correlates with poor patient outcome.

@en

Elevated ALCAM shedding in colorectal cancer correlates with poor patient outcome.

@nl

P1433

Q39173902-AAD8C8D7-0306-4830-9BAC-C63027A7D68A

P1476

Q39173902-D8C010D2-94D4-47A5-960A-38E110A740F5

P2093

Q39173902-3430E621-54C6-4448-A8F9-4F9FCC74325A

Q39173902-3A516634-98CE-4B22-9C92-2D9F45807B7A

Q39173902-5C165C83-C155-485D-B74E-C121118CF345

Q39173902-64EA80F4-839D-428F-898F-A2709D49ED69

Q39173902-9BACA90F-06D8-4ABD-BF5B-41FA85EDFB98

Q39173902-BD3ABF94-12DE-4642-A434-4DCF97AFE0F7

Q39173902-DA74689C-1CD8-4274-BB50-374D932A7C64

Q39173902-DC469CBE-9479-4C04-A244-4C219BB5AE9E

Q39173902-E0DCBCDB-4300-49A0-95DA-D265D2B8FA3E

P2860

Q39173902-04200FCB-7FE2-4330-A7C5-D9C8E66D3BA3

Q39173902-05D21DCD-1B9B-46F4-82CA-FD989402F81F

Q39173902-065171A0-F7F8-4ABA-8C8F-919A497BB5E1

Q39173902-0C27DBA1-8F31-4246-AA0A-A50ADF96F251

Q39173902-11EC757C-0701-4448-A474-3547370FADCE

Q39173902-140B9CBA-E6A5-4675-8900-248E918F37D5

Q39173902-16CFEA1A-60FC-4C47-B412-25B332941E9B

Q39173902-19AC3C6F-6B79-4763-B004-3492850DEB7C

Q39173902-1F250069-00E9-4173-B736-704B9A1E50B8

Q39173902-2B66AFC9-DE2E-4832-B961-1637D6BEBBA1

P304

Q39173902-DCF101D6-4474-4FC9-BF7C-5159C0960C4C

P31

Q39173902-B0B41858-EA0B-47BC-A3E5-03AAB7A3CBF9

P356

Q39173902-1A036A7B-AFF2-4899-B059-061DC079FF88

P407

Q39173902-CEDEC71A-F43A-4157-BA5F-8E1981347B41

P433

Q39173902-BB71CCD0-8817-4636-BB9C-BC5E2BB082BF

P478

Q39173902-6B453241-C9C6-4441-BE33-B3F828385E00

P50

Q39173902-0584DC06-5252-4ECD-90A4-58BFE9CF8DC5

Q39173902-29F15865-A915-4160-B54E-6F010075531E

P577

Q39173902-02A0E205-A6EE-4901-99D7-6BE6745CBA7D

P698

Q39173902-0C7726B0-6FB8-4FF7-B3D8-A5FFF031B778

P921

Q39173902-0DCCCAF4-A170-4197-9F29-2704B87A82AB

Q39173902-FD3DB8FA-9659-4355-B5C7-9616EFFC2063

P932

Q39173902-934EC8B7-076A-421D-9051-378E85054F09

P356

0008-5472.CAN-12-2052

P1433

Cancer Research

P1476

Elevated ALCAM shedding in colorectal cancer correlates with poor patient outcome

@en

P2093

Alina Starchenko

http://www.w3.org/2001/XMLSchema#string

Amanda G Hansen

http://www.w3.org/2001/XMLSchema#string

Celestial R Jones-Paris

http://www.w3.org/2001/XMLSchema#string

Kang-Hsien Fan

http://www.w3.org/2001/XMLSchema#string

Mary K Washington

http://www.w3.org/2001/XMLSchema#string

Michael A Gilger

http://www.w3.org/2001/XMLSchema#string

Shanna A Arnold

http://www.w3.org/2001/XMLSchema#string

Tanner J Freeman

http://www.w3.org/2001/XMLSchema#string

Yu Shyr

http://www.w3.org/2001/XMLSchema#string

P2860

CellProfiler: image analysis software for identifying and quantifying cell phenotypes

ALCAM/CD166 is up-regulated in low-grade prostate cancer and progressively lost in high-grade lesions

Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths

Prognostic significance of the cancer stem cell markers CD133, CD44, and CD166 in colorectal cancer

Truncation of activated leukocyte cell adhesion molecule: a gateway to melanoma metastasis

CellProfiler: free, versatile software for automated biological image analysis

Towards a knowledge-based Human Protein Atlas

Activated leukocyte cell adhesion molecule expression and shedding in thyroid tumors.

Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer.

Characterization of the intestinal cancer stem cell marker CD166 in the human and mouse gastrointestinal tract

P304

2955-2964

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-12-2052

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

73

http://www.w3.org/2001/XMLSchema#string

P50

Robert Daniel Beauchamp

Andries Zijlstra

P577

2013-03-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23539446

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

P932

3660148

http://www.w3.org/2001/XMLSchema#string